MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.41
-0.01 (-0.70%)
Open$1.43
Previous Close$1.42
Day High$1.43
Day Low$1.38
52W High$3.95
52W Low$1.25
Volume—
Avg Volume184.6K
Market Cap50.82M
P/E Ratio—
EPS$-2.36
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,070.2% upside
Current
$1.41
$1.41
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 24.40M | 21.48M | 24.43M |
| Net Income | -85,022,623 | -67,365,402 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -87,848,540 | -73,471,355 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |